122
Views
21
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapy of pompholyx

&
Pages 1517-1522 | Published online: 25 Feb 2005

Bibliography

  • MARKS R: The pathology and pathogenesis of the eczematous reaction. In: Eczema. Marks R (Ed.), Martin Dunitz, London, UK (1992):21–36.
  • ••Still an excellent overview on pathogenesis.
  • UTER W, GEFELLER 0, SCHWANITZ HJ: Occupational dermatitis in hairdressing apprentices. Early-onset irritant skin damage. Curc Pro& Dermatol (1995) 23:49–55.
  • LEHUCHER-MICHEL MP, KOEPPEL MC, LANTEAUME A, SAYAG J: Dyshidrotic eczema and occupation: a descriptive study. Contact Dermatitis (2000) 43(4):200–205.
  • •A thoughtful descriptive study on occupation and pompholyx.
  • MAGINA S, BARROS MA, FERREIRA JA, MESQUITA-GUIMARAESJ: Atopy, nickel sensitivity, occupation, and clinical patterns in different types of hand dermatitis. Am. Contact Dermat. (2003) 14(2):63–68.
  • SCHWANITZ HJ: Das atopische Palmoplantarekzem. Springer-Verlag, Berlin - Heidelberg - New York, USA (1985).
  • •The classical and extensive overview on (atopic) pompholyx in German.
  • COENRAADS PJ, NATER JP, JANSEN HA, LANTIGA H: Prevalence of eczema and other dermatoses of the hands and forearms in construction workers in the Netherlands. Clin. Exp. Dermatol (1984) 9(2):149–158.
  • SCHORER N, RUZICKA T: Ekzeme. Springer-Verlag, Berlin - Heidelberg - New York, USA (1999).
  • MENEGHINI CL, ANGELINI G: Contact and microbial allergy in pompholyx. Contact Dermatitis (1979) 5(1):46–50.
  • HINDSEN M, BRUZE M, CHRISTENSEN OB: Individual variation in nickel patch test reactivity. Am. J. Contact Dermal-. (1999) 10(2):62–67.
  • GAWKRODGER DJ, COOK SW, FELL GS, HUNTER JA: Nickel dermatitis: the reaction to oral nickel challenge. Br. Dermatol (1986) 115(1):33–38.
  • UYTTENDAELE H, OBADIAH J, GROSSMANN M: Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy. I Drugs Dermatol (2003) 2(3):337–341.
  • BRAUN-FALCO 0, PLEWIG G, WOLFF HH, BURGDORF WHC: Dermatology Springer-Verlag, Berlin - Heidelberg - New York, USA (2000):484–487.
  • VOCKS E, PLOTZ SG, RING J: The Dyshidrotic Eczema Area and Severity Index - A score developed for the assessment of dyshidrotic eczema. Dermatology(1999) 198 (3) :265–269.
  • ••The best evaluated clinical score for clinicalstudies in pompholyx.
  • VEIEN NK, OLHOLM LARSEN P, THESTRUP-PEDERSEN K, SCHOU G: Long-term, intermittent treatment of chronic hand eczema with mometasone fuorate. Br. J. Dermatol (1999) 140(5):882–886.
  • HARPER J: Topical corticosteroids for skin disorders in infants and children. Drugs (1988) 36\(Suppl. 5):34–37.
  • ••An excellent overview on the use oftopical corticosteroids.
  • VOLDEN G: Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm. Venereol (1992) 72(1):69–71.
  • SCHNOPP C, REMLING R, MOHRENSCHLÄGER M, WEIGL L, RING J, ABECK D: Topical tacrolimus (FK 506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. Am. Acad. Dermatol. (2002) 46(1):73–77.
  • •A controlled trial on topical steroid versus topical calcineurin inhibitor.
  • FLUHR J: Antimikrobiell wirksame Substanzen (exklusiv Antibiotika). In: Dermatologische Externathempie. Gloor M, Thoma K, Fluhr J (Eds), Springer-Verlag, Berlin - Heidelberg - New York, USA (2000):221–263.
  • SCERRI L: Azathioprine in dermatological practise. An overview with special emphasis on its use in non-bullous inflammatory dermatoses. Adv. Exp. Med. Biol. (1999) 455:343–348.
  • EGAN CA, RALLIS TM, MEADOWS KP, KRUEGER GG: Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. I Am. Acad. Dermatol (1999) 40(4):612–614.
  • PICKENACKER A, LUGER TA, SCHWARZ T: Dyshidrotic eczema treated with mycophenolate mofetil. Arch. Dermatol (1998) 134(3):378–379.
  • REITAMO S, GRANLUND H: Cyclosporin A in the treatment of chronic dermatitis of the hands. Br. I Dermatol (1994) 130(1):75–78.
  • PIGATTO PD, GIBELLI E, FUMAGALLI M, BIGARDI A, MORELLI M, ALTOMARE GF: Disodium cromoglycate versus diet in the treatment and prevention of nickel-positive pompholyx. Contact Dermatitis (1990) 22(1):27–31.
  • ••The only study on the preventionof pompholyx.
  • WOLLINA U, KARAMFILOV T: Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left-right comparison. I Eur. Acad. Dermatol Venereol (2002) 16(1):40–42.
  • •A controlled trial of adjuvant BTxA.
  • SWARTLING C, NAVER H, LINDBERG M, ANVEDEN I: Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin. J. Am. Acad. Dermatol (2002) 47(5):667–671.
  • •Controlled trial with BTxA.
  • ORFANOS CE, GARBE C: Therapie der Hautkrankheiten (2'd Edit). Springer-Verlag, Berlin - Heidelberg - New York, USA (2002).
  • HUNZIKER T, HAUDENS CHILD-FALB E, SCHMIDLI J, KREBS A: „Aqua-SUP" bei chronischen Palmoplantardermatosen. Hautarzt (1987) 38(3):165–167.
  • KRUTMANN J: Phototherapy for atopic dermatitis. Gin. Exp. Dermatol (2000) 25(7):552–558.
  • •A thorough review of phototherapy.
  • DOUWES KE, KARRER S, ABELS C, LANDTHALER M, SZEIMIES RM: Does smoking influence the efficacy of bath-PUVA therapy in chronic palmoplantar eczema? Photodermatol Photoimmunol Photomed. (2000) 16(1):25–29.
  • GRUNDMANN-KOLLMANN M, BEHRENS S, PETER RU, KERSCHER M: Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol Photoimmunol Photomed. (1999) 15(2):87–89.
  • KAPPES UP, BARTA U, MERKEL U, BALOGH A, ELSNER P: High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients. Skin Pharmacol Appl Skin Physiol. (2003) 16(5):305–312.
  • GRATTAN CE, CARMICHAEL AJ, SHUTTLEWORTH GJ, FOULDS IS: Comparison of topical PUVA with UVA for chronic vesicular hand eczema. Acta Berm. Venereol. (1991) 71(2):118–122.
  • •A comparison of PUVA and UVA therapy in pompholyx.
  • SCHMIDT T, ABECK D, BOECK K, MEMPEL M, RING J: UVA1 irradiation is effective in treatment of chronic vesicular hand eczema. Acta Berm. Venereol (1998) 78(4):318–319.
  • POLDERMAN MC, GOVAERT JC, LE CESSIE S, PAVEL S: A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin. Exp. Dermatol (2003) 28(6):584–587.
  • •One of the best controlled trials in pompholyx.
  • PETERING H, BREUER C, HERBST R, KAPP A, VVERFEL T: Comparision of localized high-dose UVA1 versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J. Am. Acad. Dermatol (2004) 50(1):68–72.
  • MAN I, IBBOTSON SH, FERGUSON J: Photoinduced pompholyx: a report of 5 cases. J. Am. Acad. Dermatol (2004) 50(1):55–60.
  • ODIA S, VOCKS E, RAKOSKI J, RING J: Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed current. Acta Berm. Venereol (1996) 76(6):472–474.
  • WOLLINA U, UHLEMANN C, ELSTERMANN D, KOBER L, BARTA U: Therapie der Hyperhidrosis mittels Leitungswasser-Iontophorese — positive Effekte auf Abheilungszeit und Rezidivfreiheit bei Hand-Ful3-Ekzemen. Hautarzt (1998) 49(2):109–113.
  • JANSEN GT: Grenz rays: adequate or antiquated?' Dermatol Sorg. °flea (1978) 4(8):627–629.
  • STAMBAUGH MD, DENITTIS AS, WALLNER PE, HEYMANN WR: Complete remission of refractory dyshidrotic eczema with the use of radiation therapy. Cutts (2000) 65(4):211–214.
  • KOLDYS KW, MEYER RP: Biofeedback training in the therapy of dyshidrosis. Culls (1979) 24(2):219–221.
  • AL-KHAFAJI M: Treatment by Chinese herbal medicine: pompholyx eczema. J. Chinese Med. (2001) 66(6):15–26.

Websites

  • http://www.pharmacymag.co.uk Pharmacy magazine: Eczema: clinical presentation and management. (Currently under development).
  • http://www.dermnetnz.org New Zealand Dermnet: Pompholyx.
  • http://www.dermatology.org/skintherapy/st10 303.html Skin Therapy Letter, Volume 3, Number 3, December (1997).
  • http://www.hkmj.org.hk/skin/public.htm LOOK CN: Blistering Diseases. In: Handbook of Dermatology & Venereology

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.